FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News

German Ophthalmological Society (DOG) – Professor Dr. Claus Cursiefen elected as Secretary General

Claus Cursiefen

The German Ophthalmological Society (DOG) elected Professor Dr. Claus Cursiefen as Secretary General for the period of four years during their 118th annual meeting in Berlin.

The renowned eye specialist´s tasks as Secretary General are assuring continuity of fundamental issues and liaising with other public and private institutions. Furthermore, Professor Cursiefen will govern the DOG headquarter in Munich.

The DOG with its 7750 members is the oldest ophthalmological society worldwide. Professor Cursiefen´s main goal during his term of office is the strengthening of ophthalmologic research and promoting the internationalization of the association.

Related posts

howald
November 17, 2020

Antonia Howaldt accepted into the Cologne Clinician Scientist Program


Read more
Coronavirus

Coronavirus

May 13, 2020

Retreat 2020 in times of Corona


Read more
MFK_4201
May 13, 2020

FOR 2240 Retreat 2019 Abbey Brauweiler


Read more

News

  • Eye clinic to win two renowned awards in the beginning of 2021
  • German Ophthalmological Society (DOG) – Professor Dr. Claus Cursiefen elected as Secretary General
  • 2nd Shanghai-Cologne Ophthalmic Research Meeting
  • Antonia Howaldt accepted into the Cologne Clinician Scientist Program
  • FOR2240 Scientist Dr. Alexander C. Rokohl was selected for the Cologne Clinician Scientist Program

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck